Live
- Chanchalguda Jail Officials Say They Haven't Received Bail Papers Yet, Allu Arjun May Stay in Jail Tonight
- BJP leaders present evidence of illegal voters in Delhi, urge EC for swift action
- Exams will not be cancelled: BPSC chairman
- Nagesh Trophy: Karnataka, T.N win in Group A; Bihar, Rajasthan triumph in Group B
- YS Jagan condemns the arrest of Allu Arjun
- Economic and digital corridors to maritime connectivity, India and Italy building vision for future, says Italian Ambassador
- SMAT 2024: Patidar's heroics guide Madhya Pradesh to final after 13 years
- CCPA issues notices to 17 entities for violating direct selling rules
- Mamata expresses satisfaction over speedy conviction in minor girl rape-murder case
- Transparent Survey Process for Indiramma Housing Scheme Directed by District Collector
ICMR to monitor city firm's work on anti Zika vaccine
The Indian Council of Medical Research (ICMR) on Thursday said it would closely monitor the proposal made by city-based Bharat Biotech for developing a vaccine for the Zika virus, which has emerged as a serious global health threat.
Hyderabad: The Indian Council of Medical Research (ICMR) on Thursday said it would closely monitor the proposal made by city-based Bharat Biotech for developing a vaccine for the Zika virus, which has emerged as a serious global health threat.
"Bharat Biotech has two proposals or ideas for development of a vaccine. One with an inactivated Zika virus and the other is a recombinant...It's a proposal. They have done some early work. In the next few months, we will closely monitor and work with them and see the progress. At the moment, we do not have a vaccine candidate," ICMR Director-General Soumya Swaminathan told the reporters.
Swaminathan is here to attend the ongoing 17th International Congress on Infectious Diseases. When pointed out that it may take several years for the vaccine to come out, she said the process of developing a substance has to go through the regulatory steps, though the process could be expedited with various stakeholders joining the endeavour and in the Public Private Partnership (PPP) mode.
Medical experts were now suggesting the idea of 'vaccine platforms' to beat the delays, Swaminathan said. "People are now talking about having platforms, create a vaccine platform. That's one of the advantages Bharat Biotech had. He (the company) had already been working on a Chikungunya vaccine.
"Because, Zika virus is quite similar, if he is able to adopt that platform, I think doing more basic research on vaccine platforms is probably equally important. Of course, it takes time... But, I think the timelines are shrinking," she said. The most common symptoms of Zika virus disease, caused by mosquito bites, are fever, rash, joint pain and red eyes.
There's no vaccine or specific treatment for the infection, known as Zika fever. The Delhi-based ICMR is the apex body in India for the formulation, coordination and promotion of biomedical research.
